U.S., Jan. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06795360) titled 'Weight Changes After Incretin-mimetics' on Jan. 22.
Brief Summary: The goal of this study is to identify people at risk of weight regain after stopping an injectable weight loss drug. The main question we aim\ to answer is: can weight regain be predicted by measuring circulating Agouti-related peptide, a small protein coming from the brain?
Study Start Date: Dec. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Obesity and Obesity-related Medical Conditions
Intervention:
OTHER: discontinuation of weight loss medication
Participants will be studied right before their injectable weight loss medication runs out, and 3 months later...